PUT/MERCK & CO./80/0.1/20.06.25 | Real-time BOERSE MUENCHEN 08:25:51 2024-07-11 am EDT | ||
| 0.063 EUR | -4.55% |
|
| 1 month | -2.94% | ||
| 3 months | -25.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 0.063 | -4.55% |
| 24-07-10 | 0.066 | -1.49% |
| 24-07-09 | 0.067 | +4.69% |
| 24-07-08 | 0.064 | -1.54% |
| 24-07-05 | 0.065 | 0.00% |
Real-time BOERSE MUENCHEN
Last update July 11, 2024 at 08:25 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GQ8XD3 |
| ISIN | DE000GQ8XD32 |
| Date issued | 2023-11-13 |
| Strike | 80 $ |
| Maturity | 2025-06-20 (344 Days) |
| Parity | 10 : 1 |
| Emission price | 0.3 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.329 € |
|---|---|
| Lowest since issue | 0.056 € |
| Spread | 0.05 € |
| Spread % | 45.45% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
127.3
USD
Average target price
142.6
USD
Spread / Average Target
+11.99%
- Stock Market
- Warrants
- Warrant
